Email not displaying properly? View email in your browser
Vertical-Talk Pharma   >  Nanotherapeutics Strategies
>  Cancer Treatment
>  Biospecific Antibody
  June 2021   e-Newsletter Advertise | Editorial Calendar  
Next Generation Cellular Therapeutic Technologies
Latest e-book
News
Eisai and Biogen Inc. Announce U.S. FDA Grants Breakthough...
Amgen Announces Approval Of Aimovig® (Erenumab) In Japan...
Press Releases
Shimadzu launches LabSolutions BiX - World’s first Analytically...
The increase of vaccines production boosts the demand of EtO...
Events
28 - 30 Jun 2021
ICPPN Germany 2021
28 - 29 Jun 2021
PHARMAP 2021
13 - 15 Jul 2021
ARDS Drug Summit 2021
Articles
>  Commissioning the 505(b)(2) Pathways in Hastening the Clinical      Translation of Various Drugs via Nanotechnological Approaches
Saurabh Srivastava, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research
The era of nanomedicine-based products has revolutionised the science of drug delivery. Compared to the conventional delivery systems, nanotherapeutics possesses several advantages attributed to the nanometric dimension. The authors recommend the utilisation...
Techno Trends
> Novel Elecsys Growth Differentiation Factor-15 (GDF-15) Assay...
> Novel HER2-Targeted Bispecific Antibody Zanidatamab Developed for...
Projects
> Cambrex to Expand Large Scale API Manufacturing Capacity in US
> Piramal PharmaPlans New Manufacturing Facility in Michigan
Lonza Capsugel® Zephyr™ Dry-Powder Inhalation Capsule Portfolio
Research Insights
> Evaluation of classification and forecasting methods on time series...
> Global gene network exploration based on explainable artificial...
  Subscribe  |  e-Book Archives  | Advisory Board  
Follow Us Facebook Twitter linkedin
www.pharmafocusasia.com - Owned by Ochre Media Pvt. Ltd.